Advances in the treatment of locally advanced rectal cancer

Fadwa Ali, Ajaratu Keshinro, Martin R. Wesiser

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations


Locally advanced rectal cancer requires multidisciplinary care. In the United States, most patients are treated with neoadjuvant chemoradiation delivered over 25-28 days, total mesorectal excision, and 4 months of adjuvant chemotherapy. While effective, this trimodal approach is arduous. Alternative approaches have emerged to streamline treatment without sacrificing oncologic outcomes. These approaches include preoperative chemotherapy with selective use of radiation, short-course radiotherapy delivered over 5 days, and total neoadjuvant therapy with attempted nonoperative organ-preserving management (watch and wait). Ongoing trials are assessing the efficacies of these approaches in combination with various risk stratification strategies.

Original languageEnglish (US)
Pages (from-to)32-38
Number of pages7
JournalAnnals of Gastroenterological Surgery
Issue number1
StatePublished - Jan 2021
Externally publishedYes


  • locally advanced rectal cancer
  • nonoperative management
  • total mesorectal excision
  • total neoadjuvant therapy
  • watch and wait

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology


Dive into the research topics of 'Advances in the treatment of locally advanced rectal cancer'. Together they form a unique fingerprint.

Cite this